Childhood asthma: Exhaled markers of airway inflammation, asthma control score, and lung function tests
Corresponding Author
Philippe P.R. Rosias MD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Department of Pediatrics, Maasland Hospital, Sittard, The Netherlands
Department of Pediatrics, Maasland Hospital, PO Box 5500, 6130 MB Sittard, The Netherlands.Search for more papers by this authorEdward Dompeling MD, PhD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorMieke A. Dentener PhD
Department of Respiratory Medicine, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorHerman J. Pennings MD, PhD
Department of Respiratory Medicine, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorHan J.E. Hendriks MD, PhD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorMonique P.A. Van Iersel MD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorQuirijn Jöbsis MD, PhD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorCorresponding Author
Philippe P.R. Rosias MD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Department of Pediatrics, Maasland Hospital, Sittard, The Netherlands
Department of Pediatrics, Maasland Hospital, PO Box 5500, 6130 MB Sittard, The Netherlands.Search for more papers by this authorEdward Dompeling MD, PhD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorMieke A. Dentener PhD
Department of Respiratory Medicine, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorHerman J. Pennings MD, PhD
Department of Respiratory Medicine, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorHan J.E. Hendriks MD, PhD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorMonique P.A. Van Iersel MD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorQuirijn Jöbsis MD, PhD
Department of Pediatric Pulmonology, University Hospital Maastricht, Maastricht, The Netherlands
Search for more papers by this authorAbstract
Exhaled markers of airway inflammation become increasingly important in the management of childhood asthma. The aims of the present study are: 1) to compare exhaled markers of inflammation (nitric oxide, carbon monoxide, and acidity of breath condensate) with conventional asthma measures (lung function tests and asthma control score) in childhood asthma; and 2) to investigate the detectability of albumin, CRP, IL-6, IL-8, TNF-alpha, sICAM-1, and sTNF-R75 in the exhaled breath condensate (EBC) of asthmatic children. Thirty-two children with mild to moderate persistent asthma and healthy controls aged 6–12 years were studied. We measured exhaled NO and CO, and subsequently EBC was collected. Inflammatory mediators in EBC were measured using an enzyme-linked immunosorbent assay. Respiratory symptoms and asthma control were assessed using the asthma control questionnaire (ACQ) of Juniper et al. (Eur Respir J 1999;14:902–907). Exhaled NO showed a significant correlation with exhaled CO (r = 0.59, P < 0.05) and FEV1 (r = −0.59, P < 0.05), but not with ACQ score (r = 0.48, P = 0.06). Exhaled CO was correlated with prebronchodilator FEV1 (r = −0.45, P < 0.05), but not with asthma control (r = 0.18, P = 0.35). Acidity of EBC was significantly lower in asthmatic children than in healthy controls (P < 0.05), but did not correlate with any of the conventional asthma measures. We were not able to demonstrate the presence of CRP, IL-6, IL-8, TNF-alpha, sICAM-1, and sTNF-R75 in EBC. Albumin was found in two EBC samples of asthmatic children. We conclude that exhaled NO had a better correlation with lung function parameters and asthma control than exhaled CO and acidity of EBC, in mild to moderate persistent childhood asthma. However, exhaled NO, CO, and deaerated pH of EBC did not differ between asthmatic children and controls, possibly because of a too homogeneous and well-controlled study population. To further evaluate the clinical utility of exhaled markers in monitoring childhood asthma, more studies are required on a wider range of asthma severity, and preferably with repeated measurements of markers and of asthma control. Pediatr Pulmonol. 2004; 38:107–114. © 2004 Wiley-Liss, Inc.
REFERENCES
- 1 National Asthma Education and Prevention Program Expert Panel Report. Guidelines for the diagnosis and management of asthma, update on selected topics—2002. J Allergy Clin Immunol 2002; Supp 141–219.
- 2 Standards for diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244.
- 3 Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693–1722.
- 4 Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide and breath condensate. Eur Respir J 2000; 16: 1008–1015.
- 5 Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16: 781–792.
- 6 Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57: 889–896.
- 7 Warke TJ, Fitch PS, Brown V, Taylor R, Lyons JDM, Ennis M, Shields MD. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002; 57: 383–387.
- 8 La Grutta S, Gagliardo R, Mirabella F, Pajno GB, Bonsignore G, Bousquet J, Bellia V, Vignola AM. Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med 2003; 167: 1490–1495.
- 9 Payne DNR, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001; 164: 1376–1381.
- 10 Payne DNR, Wilson NM, James A, Hablas H, Agrafioti C, Bush A. Evidence for different subgroups of difficult asthma in children. Thorax 2001; 56: 345–350.
- 11 Donnelly LE, Barnes PJ. Expression of heme oxygenase in human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 24: 295–303.
- 12
Yilmaz O,
Ozturk F,
Bakirtas A,
Cengizlier R,
Turktas I.
Exhaled carbon monoxide levels in children with bronchial asthma.
Pediatr Asthma Allergy Immunol
2003;
16:
155–162.
10.1089/088318703322247633 Google Scholar
- 13 Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161: 694–699.
- 14 Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54: 825–857.
- 15 Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998; 50: 515–596.
- 16 Marguet C, Dean TP, Basuyau JP, Warner JO. Eosinophil cationic protein and interleukin-8 levels in bronchial lavage fluid from children with asthma and infantile wheeze. Pediatr Allergy Immunol 2001; 12: 27–33.
- 17 Tang ML, Fiscus LC. Important roles for L-selectin and ICAM-1 in the development of allergic airway inflammation in asthma. Pulm Pharmacol Ther 2001; 14: 203–210.
- 18 Marguet C, Dean TP, Warner JO. Soluble intercellular adhesion molecule-1 (sICAM-1) and interferon-gamma in bronchoalveolar lavage fluid from children with airway diseases. Am J Respir Crit Care Med 2000; 162: 1016–1022.
- 19 Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop report. National Institutes of Health, December 1995. Publication no. 95-3659. National Heart Lung and Blood Institute. Bethesda, MD. 1995.
- 20 Tammeling GJ, Quanjer PH, on behalf of Report Working Party. Standardized lung function testing. Eur Respir J [Suppl] 1993; 6: 5–40.
- 21 American Thoracic Society. Recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999; 160: 2104–2117.
- 22 Uasuf CG, Jatakanon A, James A, Kharitonov SA, Wilson NM, Barnes PJ. Exhaled carbon monoxide in childhood asthma. J Pediatr 1999; 135: 569–574.
- 23 Jöbsis Q, Raatgreep HC, Hemans PWM, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997; 10: 519–521.
- 24 Leeuwenberg JF, Jeunhomme TM, Buurman WA. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994; 152: 4036–4043.
- 25 Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993; 150: 2885–2891.
- 26 Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994; 153: 4159–4168.
- 27 Engelberts I, Moller A, Schoen GJ, van der Linden CJ, Buurman WA. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991; 10: 69–76.
- 28 Bouma MG, Laan MP, Dentener MA, Buurman WA. Analysis of soluble adhesion molecules. In: AP Johnstone, MW Turner, editors. Immunochemistry 2: a practical approach. Oxford: Oxford University Press; 1997. p 181.
- 29 Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002; 166: 1218–1224.
- 30 Juniper EF, O'Bryne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902–907.
- 31 Piacentini GL, Bodini A, Costella S, Suzuki Y, Zerman L, Peterson CG, Boner AL. Exhaled nitric oxide, serum ECP and airway responsiveness in mild asthmatic children. Eur Respir J 2000; 15: 839–843.
- 32 Spallarossa D, Battistini E, Silvestri M, Sabatini F, Biraghi MG, Rossi GA. Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma. J Asthma 2001; 38: 545–553.
- 33 Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002; 57: 586–589.
- 34 Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn JD. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142: 469–475.
- 35 Henderson AC, Ingenito EP, Atileh H, Israel E, Suki B, Lutchen KR. How does airway inflammation modulate asthmatic airway constriction? An antigen challenge study. J Appl Physiol 2003; 95: 873–882.
- 36 Sterk PJ. Non-invasive monitoring of bronchial inflammation in asthma. Schweiz Med Wochenschr 1997; 127: 1686–1692.
- 37 Paredi P, Leckie MJ, Horvath I, Allegra L, Kharitonov SA, Barnes PJ. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999; 13: 48–52.
- 38 Yamaya M, Hosoda M, Ishizuka S, Monma M, Matsui T, Suzuki T, Sekizawa K, Sasaki H. Relation between exhaled carbon monoxide levels and clinical severity of asthma. Clin Exp Allergy 2001; 31: 417–422.
- 39 Zanconato S, Scollo M, Zaramella C, Landi L, Zacchello F, Baraldi E. Exhaled carbon monoxide levels after a course of oral prednisone in children with asthma exacerbation. J Allergy Clin Immunol 2002; 109: 440–445.
- 40 Baraldi E, de Jongste JC, on behalf of European Respiratory Society/American Society Task Force. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002; 20: 223–237.
- 41 Ece A, Gurkan F, Haspolat K, Derman O, Kirbas G. Passive smoking and expired carbon monoxide concentrations in healthy and asthmatic children. Allergol Immunopathol 2000; 28: 255–260.
- 42 Beck-Ripp J, Griese M, Arenz S, Köring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002; 19: 1015–1019.
- 43 Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165: 1364–1370.
- 44 Van Rensen ELJ, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction. Am J Respir Crit Care Med 2002; 165: 1275–1279.
- 45 Cunningham S, McColm JR, Pei Ho L, Greening AP, Marshall TG. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000; 15: 955–957.
- 46 Rosias PR, Dompeling E, Hendriks HJE, Heijnens JWCM, Donckerwolcke RAMG, Jöbsis Q. Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol 2004; 15: 4–19.
- 47 Jeffery P. Inflammation and remodeling in the adult and child with asthma. Pediatr Pulmonol 2001; 21: 3–16.
- 48 Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Tura M, Zuin R, Beghé B, Maestrelli P, Fabbri LM, Saetta M. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003; 168: 798–803.
- 49 Zeiger RS, Dawson C, Weiss S. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol 1999; 103: 376–387.
- 50 Fish JE, Peters SP. Asthma severity: histopathologic correlations. Drugs Today (Barc) 1999; 35: 585–594.
- 51 Magnussen H. Inhalation therapy for bronchial asthma: strategies and targets. Curr Opin Pulm Med [Suppl] 2003; 9: 3–7.